According to the latest report by IMARC Group, titled “Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global autoimmune disease diagnosis market reached a of US$ 4.4 Billion in 2020 and expected to grow at a CAGR of 8.10% during 2021-2026.
An autoimmune disease refers to a medical condition that results from an abnormal immune response to a normally functioning body part. The immune system is unable to distinguish between healthy tissues and potentially harmful antigens in this condition. As a result, it releases proteins called autoantibodies to attack the healthy cells that destroy the functioning cells, tissues, and organs of the body. At present, more than 80 types of autoimmune disorders have been identified by scientists that include type I diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The diagnosis of these diseases requires a combination of physical examination, antinuclear antibody test (ANA), C-reactive protein (CRP), tissue biopsy and X-rays in order to determine the nature and severity of the condition.
Request Free Sample Report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample
Global Autoimmune Disease Diagnosis Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Aesku.Diagnostics GmbH & Co. KG, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA (Institut Merieux), Bio-Rad Laboratories Inc., Euroimmun AG (PerkinElmer Inc.), Hemagen Diagnostics Inc., Inova Diagnostics Inc. (Werfen Group S.A.), Myriad Genetics Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens AG), SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech, etc.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market
The report has segmented the market on the basis of product, disease, test, user and Region
Breakup by Product Type:
- Consumables and Assay Kits
- Instruments
Breakup by Disease Type:
- Systemic Autoimmune Disease
- Localized Autoimmune Disease
Breakup by Test Type:
- Routine Laboratory Tests
- Inflammatory Markers
- Autoantibodies and Immunologic Tests
- Others
Breakup by End-User:
- Clinical Laboratories
- Hospitals
- Others
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: [email protected]
Website: https://www.imarcgroup.com